Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
Status:
Completed
Trial end date:
2016-09-13
Target enrollment:
Participant gender:
Summary
This study has several purposes. DCE-MRI will be used to image the tumor. Safety of cetuximab
given before surgery will be studied. Cetuximab delivery to the tumor will be studied. In
Stage 2 of this study, the safety of cetuximab and PEGPH20 given before surgery will be
studied. Also, the effects of PEGPH20 on tumors will be studied.
Phase:
N/A
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborators:
Cold Spring Harbor Laboratory Weizmann Institute of Science